The primary objective of this study is to examine whether web-based Wegweis tool can support processes of shared decision making in ROM evaluation and treatment planning regarding people with psychotic disorders.
ID
Source
Brief title
Condition
- Schizophrenia and other psychotic disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The amount of *shared decision making* between patient and clinician: Measured
with theMAPPIN SDM scale (rating of audiotaped evaluation meeting between
clinician and patient).
Secondary outcome
• Quality of working alliance between patient and clinician
• Patient perceived benefit of ROM
Background summary
Since 2007, ROM assessments have been a regular element in care for people with
psychotic disorders in the northern provinces of the Netherlands. However, a
large percentage of service users do not receive adequate feedback concerning
their ROM-results, as clinicians are not yet accustomed to discussing ROM
results with service users. In an attempt to improve ROM practice and to
increase potential for service user empowerment, we developed a prototype of a
web-based support system called Wegweis that provides service users diagnosed
with schizophrenia with personalized advice, based on their ROM results. By
means of this support system, the current problems with ROM practice may be
partly tackled. A usability study has shown that people with psychotic
disorders can work with the Wegweis system (Van der Krieke et al., 2012). In
this pilot study, we aim to investigate whether the Wegweis system can
contribute to processes of shared decision making between patients and
clinicians with regard to ROM results.
Study objective
The primary objective of this study is to examine whether web-based Wegweis
tool can support processes of shared decision making in ROM evaluation and
treatment planning regarding people with psychotic disorders.
Study design
Pilot randomized controlled trial, 2x n=30
Intervention
The intervention is behavioural in nature; it should lead to more patient
involvement in medical decision making. In the intervention condition, patients
are invited to use the web-based Wegweis system. This web system provides
patients with information about ROM, access to their ROM results, and access to
individualized advice based on these ROM results. (Patients in the control
condition receive care as usual).
Study burden and risks
The intervention has a duration of 9 months, during which patients in the
intervention group will be invited to use the Wegweis system. Furthermore, all
patients will be asked to complete self-report questionnaires twice, they will
be interviewed once, and we will ask for patients* approval to audiotape a
meeting with their clinician in which ROM results are discussed. Patients
involved in the study can benefit from the intervention in that it aims to
increase their involvement in the treatment planning process. As far as we
know, there are no risks involved.
Hanzeplein 1
Groningen 9700 RB
NL
Hanzeplein 1
Groningen 9700 RB
NL
Listed location countries
Age
Inclusion criteria
- >18 year
- patients with psychotic disorders
- participating in Phamous assessments (= ROM assessments for people with a psychotic disorder)
- fluent in Dutch
Exclusion criteria
N/A
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL43102.042.12 |